Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01569243 · ClinicalTrials.gov registry record · Phase 2
Text to Move (TTM)Study
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 126
- Enrollment target
NCT01569243: Completed Phase 2 study, sponsored by Massachusetts General Hospital.
NCT01569243 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01569243, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 126 participants
- Enrollment target
Study Summary
This study is a 2-arm randomized controlled trial examining the effect of personalized text messages on physical activity and clinical outcomes in patients with type 2 diabetes mellitus. The investigators hypothesize that: i. The use of personalized text messages will promote physical activity in patients with T2DM. ii. Increased physical activity and behavior change correlate with better clinical outcomes (Change in HbA1c). iii. The text messaging program will lead to sustained physical activity behavior change in patients with T2DM
Interventions
- OTHER Usual care
- OTHER Text messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01569243
The ClinicalTrials.gov registry entry for NCT01569243 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT01569243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01569243 about?
NCT01569243 is a clinical study titled "Text to Move (TTM)Study". This study is a 2-arm randomized controlled trial examining the effect of personalized text messages on physical activity and clinical outcomes in patients with type 2 diabetes mellitus. The investigators hypothesize that: i. The use of personalized text messages will promote physical activity in ...
What is the current status of trial NCT01569243?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 126 participants. The study started on 2012-06. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01569243?
The interventions under investigation include: Usual care (OTHER), Text messages (OTHER).
Who is sponsoring clinical trial NCT01569243?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.